GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, firstname.lastname@example.org
Product name : Fmoc_OSu
Catalog number : 1042
Supplier name : Sceti K.K.
Data sheet: Ask more or other datasheet now !
More Details about
Human sera, especially from patients with autoimmune diseases, contain high levels of immunoreactive components, which yield high background levels in ELISA systems. These non-specific reactions are caused by adhesive immunoglobulins contained in human serum, which strongly adhere to plastic surfaces by hydrophilic binding, and blocking agents such as bovine serum albumin (BSA) and Tween 20, are not capable of blocking these non-specific reactions at all. However, these false positive reactions caused by serum sample itself have not been understood, and are considered as a real antibodyantigen reaction in many cases, even now. In order to obtain a real value of antigen-antibody reaction, it is critical 1) to choose proper blocking agents which block these kinds of non-specific reactions effectively, 2) to determine a unique non-specific background value of individual samples using antigen-non-coated wells and 3) to subtract the background value from the value determined in antigen-coated wells. In addition, it is apparent to determine the non-specific reactions caused by secondary antibody as well. Chondrex’s ELISA system incorporates unique blocking agents that inhibit the hydrophobic binding of these serum components onto plastic surfaces and are designed
to determine the background values of individual samples using antigen-non-coated wells.
IgA antibodies to type II collagen are often associated with IgG antibodies in human sera. Importantly, IgA and IgG antibodies share identical collagen types and species specificity in individual sera, suggesting that the same collagen is involved in eliciting these antibodies. Therefore, it is highly likely that heterologous collagen in diets may play a primary role in the anti-collagen antibody production, regardless of the disease.
However, this does not indicate that only type II collagen is always the eliciting antigen, since type I collagen, found abundantly in diets, share amino acid sequences with type II collagen by more than 80% and the antibodies in human sera often react to both type I and type II collagen.
To determine the diversity of anti-collagen antibodies in human sera, Chondrex provides IgA and IgG antibody assay kits with various species of type I and type II collagen-coated strips as well as uncoated wells (see table above). This ELISA kit contains enough materials to run two plates on two separate occasions (see assay procedure) and may be used for monkey sera as well as human sera.
Note: Since IgA and IgG antibodies in human sera share similar collagen types and species of specificity, it is assumed that IgA antibodies determined by this ELISA kit might be underestimated due to the competitive binding of IgG antibodies to the identical epitopes on collagen molecules. In order to determine accurate IgA antibody levels in human serum samples, it is recommended to treat serum samples with Protein G to remove IgG antibodies.
NOTES BEFORE USING ASSAY
Note 1: It is recommended that the standard and samples be run in duplicate.
Note 2: Partially used reagents may be kept at –20°C.
Note 3: Crystals may form in the 20X wash buffer when stored at cold temperatures. If crystals have formed, it is necessary to warm the wash buffer by placing the bottle in warm water until crystals have dissolved completely.
Note 4: Measure exact volume of buffers using a serological pipette prior to diluting. Extra buffer is provided.
1. Dilute Wash Buffer: Dilute 50 mL of 20X wash buffer in 950 mL of distilled water (1X wash buffer). Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
2. Add Blocking Buffer: Add 100 mL of Blocking Buffer (Solution A) to all wells. Incubate for 1 hour at room temperature.
3. Prepare Standard Dilutions: Undiluted standard is 16 units/mL. Prepare serial dilutions of the standard by mixing 250 mL of 16 units/mL standard with 250 mL of Sample/Standard Dilution Buffer (Solution B) - 8 units/mL . Then repeat this procedure to make five more serial dilutions of standard - 4, 2, 1, 0.5 and 0.25 units/mL solutions. The 16 units/mL standard may be stored at -20°C for use
in a second assay. We recommend making fresh serial dilutions for each assay.
4. Prepare Sample Dilutions: Dilute samples 1:100 or more with Solution B. For example, dilute 20 mL of sample with 1.98 mL of Solution B (1:100). Keep this as a stock solution for future assays. If necessary, dilute the samples further with Solution B, 1:200-1:1000.
Note: Human serum samples have a high lipid content in general. In order to avoid non-specific reactions caused by lipids, centrifuge samples at 10,000 rpm for 5 minutes using a tabletop centrifuge. Take a desired volume of serum sample carefully by pipette and then wipe the pipette surface with paper.
5. Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
6. Add Standards and Samples: Add 100 mL of standards, Solution B (blank), and samples to collagen coated and uncoated wells in duplicate. Incubate at 4°C overnight.
7. Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
8. Add Secondary Antibody: Dissolve one vial of secondary antibody in 10 mL Secondary Antibody Dilution Buffer (Solution C1).
Add 100 mL of secondary antibody solution to each well and incubate at room temperature for 2 hours.
9. Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
10. Add Streptavidin Peroxidase: Dilute one vial of Streptavidin Peroxidase in 10 mL of Streptavidin Peroxidase Dilution Buffer (Solution C2). Add 100 mL of streptavidin peroxidase solution to each well and incubate at room temperature for 1 hour.
11 . Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
12. OPD: Dissolve one vial of OPD in 10 mL of OPD Dilution Buffer just prior to use. Add 100 mL of OPD solution to each well immediately after washing the plate. Incubate for 30 minutes at room temperature.
13. Stop: Add 50 mL of 2N sulfuric acid (Stop Solution) to each well.
14. Read Plate: Read the OD values at 490 nm. If the OD values of samples are greater than the OD values of the highest standard, re-assay the samples at a higher dilution. A 630 nm filter can be used as a reference.
CALCULATION OF ANTIBODY TITERS
1. Average the duplicate OD values for the standards, blanks (B) and test samples in uncoated wells and collagen coated wells.
2. Subtract the blank (B) values from the averaged OD values of the standards and test samples in uncoated wells and collagen coated wells.
Note: Individual antigens have unique background values. Therefore, blank wells should be used for each different antigen.
3. Subtract the OD values of samples tested in uncoated wells (background values) from their counterpart OD values in collagen coated wells from step 2 to eliminate values associated with non-specific reactions.
4. Plot the OD values of standards against the units/mL of antibody standard. Using a log/log plot will linearize the data. Figure 3 shows a representative experiment where the standard range is from 0.25 to 16 units/mL.
5. The units/mL of antibody in test samples can be calculated using regression analysis.
Contact us about this product :
Our team will respond you as soon as possible !
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
email@example.com | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
No related Items
Related Genes :
[QUA2 OSU1 TSD2 At1g78240 F3F9.21 T11I11.18] Probable pectin methyltransferase QUA2 (EC 2.1.1.-) (Protein OVERSENSITIVE TO SUGAR 1) (Protein QUASIMODO 2) (Protein TUMOROUS SHOOT DEVELOPMENT 2)
[COI] Cytochrome c oxidase subunit 1 (EC 18.104.22.168) (Fragment)
[OnmyUAA-OSU Onmy-UBA Onmy-UBA*1] MHC class I (MHC class I heavy chain) (MHC class IA antigen) (MHC class Ia heavy chain)
[glmU FTH_0450] Bifunctional protein GlmU [Includes: UDP-N-acetylglucosamine pyrophosphorylase (EC 22.214.171.124) (N-acetylglucosamine-1-phosphate uridyltransferase); Glucosamine-1-phosphate N-acetyltransferase (EC 126.96.36.199)]
 Replicase large subunit (EC 2.1.1.-) (EC 2.7.7.-) (EC 188.8.131.52) (EC 184.108.40.206) (183 kDa protein) (RNA-directed RNA polymerase) [Cleaved into: Replicase small subunit (EC 2.1.1.-) (EC 2.7.7.-) (EC 220.127.116.11) (126 kDa protein) (Methyltransferase/RNA helicase) (MT/HEL)]
[murE MCI_01765] UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (EC 6.3.2.-) (EC 18.104.22.168) (Meso-A2pm-adding enzyme) (Meso-diaminopimelate-adding enzyme) (UDP-MurNAc-L-Ala-D-Glu:meso-diaminopimelate ligase) (UDP-MurNAc-tripeptide synthetase) (UDP-N-acetylmuramyl-tripeptide synthetase)
[rlmN FTH_1004] Dual-specificity RNA methyltransferase RlmN (EC 22.214.171.124) (23S rRNA (adenine(2503)-C(2))-methyltransferase) (23S rRNA m2A2503 methyltransferase) (Ribosomal RNA large subunit methyltransferase N) (tRNA (adenine(37)-C(2))-methyltransferase) (tRNA m2A37 methyltransferase)
[cobA cysG L533_1422] Siroheme synthase
[glmU L533_5191] Bifunctional protein GlmU
[pyrG FTH_1283] CTP synthase (EC 126.96.36.199) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase)
[asd MCI_06340] Aspartate-semialdehyde dehydrogenase (ASA dehydrogenase) (ASADH) (EC 188.8.131.52) (Aspartate-beta-semialdehyde dehydrogenase)
[eno FTH_1477] Enolase (EC 184.108.40.206) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)
[pyrG MCI_06810] CTP synthase (EC 220.127.116.11) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (UTP--ammonia ligase)
[rlmN L533_3391] Dual-specificity RNA methyltransferase RlmN (EC 18.104.22.168) (23S rRNA (adenine(2503)-C(2))-methyltransferase) (23S rRNA m2A2503 methyltransferase) (Ribosomal RNA large subunit methyltransferase N) (tRNA (adenine(37)-C(2))-methyltransferase) (tRNA m2A37 methyltransferase)
[panD FTH_0675] Aspartate 1-decarboxylase (EC 22.214.171.124) (Aspartate alpha-decarboxylase) [Cleaved into: Aspartate 1-decarboxylase beta chain; Aspartate 1-decarboxylase alpha chain]
[ackA FTH_0015] Acetate kinase (EC 126.96.36.199) (Acetokinase)
[ftsH MCI_04515] ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)
[serS MCI_03320] Serine--tRNA ligase (EC 188.8.131.52) (Seryl-tRNA synthetase) (Seryl-tRNA(Ser/Sec) synthetase)
[pdxT FTH_1495] Pyridoxal 5'-phosphate synthase subunit PdxT (EC 184.108.40.206) (Pdx2) (Pyridoxal 5'-phosphate synthase glutaminase subunit) (EC 220.127.116.11)
[asd L533_2281] Aspartate-semialdehyde dehydrogenase (ASA dehydrogenase) (ASADH) (EC 18.104.22.168) (Aspartate-beta-semialdehyde dehydrogenase)
[fni MCI_00875] Isopentenyl-diphosphate delta-isomerase (IPP isomerase) (EC 22.214.171.124) (Isopentenyl diphosphate:dimethylallyl diphosphate isomerase) (Isopentenyl pyrophosphate isomerase) (Type 2 isopentenyl diphosphate isomerase)
[coaX2 FTH_1606] Type III pantothenate kinase 2 (EC 126.96.36.199) (PanK-III 2) (Pantothenic acid kinase 2)
[coaX1 FTH_0674] Type III pantothenate kinase 1 (EC 188.8.131.52) (PanK-III 1) (Pantothenic acid kinase 1)
[ilvC L533_4150] Ketol-acid reductoisomerase (NADP(+)) (KARI) (EC 184.108.40.206) (Acetohydroxy-acid isomeroreductase) (Alpha-keto-beta-hydroxylacyl reductoisomerase) (Ketol-acid reductoisomerase type 1) (Ketol-acid reductoisomerase type I)
[hmp L533_3286] Flavohemoprotein (Flavohemoglobin) (Hemoglobin-like protein) (Nitric oxide dioxygenase)
[purT FTH_0087] Phosphoribosylglycinamide formyltransferase 2 (GART 2) (EC 2.1.2.-) (5'-phosphoribosylglycinamide transformylase 2) (Formate-dependent GAR transformylase) (GAR transformylase 2)
[katG FTH_1458] Catalase-peroxidase (CP) (EC 220.127.116.11) (Peroxidase/catalase)
[serS FTH_1445] Serine--tRNA ligase (EC 18.104.22.168) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)
[ddl FTH_1833] D-alanine--D-alanine ligase (EC 22.214.171.124) (D-Ala-D-Ala ligase) (D-alanylalanine synthetase)
[pyrG L533_3959] CTP synthase (EC 126.96.36.199) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (UTP--ammonia ligase)
 Rapid separation of phosphopeptides by microchip electrophoresis-electrospray ionization mass spectrometry.
 Controllable core-shell-type resin for solid-phase peptide synthesis.
 Immobilization of aptamer-based molecular beacons onto optically-encoded micro-sized beads.
 Formation of Fmoc-beta-alanine during Fmoc-protections with Fmoc-OSu.
 Synthesis and solid-phase application of suitably protected gamma-hydroxyvaline building blocks.
 Fmoc-2-mercaptobenzothiazole, for the introduction of the Fmoc moiety free of side-reactions.
 Traceless capping agent for peptide sequencing by partial edman degradation and mass spectrometry.
 Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulin.
 Efficient asymmetric synthesis of (S)- and (R)-N-Fmoc-S-trityl-alpha-methylcysteine using camphorsultam as a chiral auxiliary.
 Synthesis of novel basic head-to-side-chain cyclic dynorphin A analogs: strategies and side reactions.
Enter catalog number :